Clinical Trial

Prevention of Hernia After Loop Ileostomy Reversal

Study acronym: PHaLIR
Recruiting Phase 2/3
View on ClinicalTrials.gov →
Summary
PHaLIR is a prospective, double-blinded randomized study in which patients planned for stoma reversal after rectal cancer surgery are randomized between retro muscular mesh Ultrapro Advanced or standard treatment without mesh.
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2018-10-24; most recent amendment 2025-08-14.
Trial Details
NCT Number NCT03720262
Lead Sponsor Karolinska Institutet
Collaborators: Stockholm South General Hospital
Conditions Loop Ileostomy
Enrollment 208 participants
Start Date 2018-03-01
Primary Completion 2026-12-31 (estimated)
Study Completion 2029-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-08-19